Newron Pharmaceuticals S.p.A. Stock
Stocks
NWRN
IT0004147952
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.42 CHF | -0.35% |
|
-3.38% | -52.12% |
| 07-03 | Newron Pharmaceuticals to Make Changes to Phase 3 Trial of Schizophrenia Treatment | MT |
| 05-05 | Edison Is Not Overly Concerned About a Trial Suspension |  |
| Market Cap | 257M 294M 238M 218M 413M 28.33B 420M 2.83B 1.11B 13.86B 1.1B 1.08B 47.74B | P/E 2026 * |
-9.1x | P/E 2027 * | 33.4x |
|---|---|---|---|---|---|
| Enterprise Value | 296M 338M 274M 251M 475M 32.59B 483M 3.26B 1.28B 15.95B 1.27B 1.24B 54.92B | EV / Sales 2026 * |
27.3x | EV / Sales 2027 * | 6.06x |
| Free-Float |
86.89% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Newron Pharmaceuticals S.p.A.
| 1 day | -0.35% | ||
| 1 week | -3.38% | ||
| Current month | -12.42% | ||
| 1 month | -5.62% | ||
| 3 months | -32.67% | ||
| 6 months | -54.86% | ||
| Current year | -52.12% |
| 1 week | 11.34 |  | 12.24 |
| 1 month | 11.34 | | 13.18 |
| Current year | 11.34 | | 31.85 |
| 1 year | 6.5 | | 31.85 |
| 3 years | 4.09 | | 31.85 |
| 5 years | 1.01 | | 31.85 |
| 10 years | 0.9 | | 31.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stefan Weber
CEO | Chief Executive Officer | 62 | 2012-05-14 |
Roberto Galli
DFI | Director of Finance/CFO | - | 2011-12-31 |
Filippo Moriggia
COO | Chief Operating Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Stefan Weber
BRD | Director/Board Member | 62 | 2012-05-14 |
Gillian Dines
BRD | Director/Board Member | - | 2023-03-31 |
Margarita Chavez
BRD | Director/Board Member | - | 2024-04-16 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/3/25 | Sell | 5,465 | 0.0274% | |||
| 12/3/25 | Fiscal year | Founder | 5,465 | 0.0274% | ||
| 11/27/25 | Fiscal year | Founder | 14,567 | 0.0730% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.35% | -3.38% | +60.62% | +99.65% | 296M | |
| -1.07% | +0.38% | +2.06% | +5.66% | 50.35B | |
| -2.85% | -5.58% | +373.90% | +572.09% | 39.21B | |
| +1.78% | +3.29% | +33.49% | -4.80% | 34.52B | |
| +1.98% | +5.15% | +17.69% | +61.68% | 34.6B | |
| +0.06% | -0.57% | +3.35% | +27.42% | 27.05B | |
| -3.27% | -6.27% | - | - | 16.68B | |
| +1.64% | +1.11% | +72.02% | +121.18% | 15.11B | |
| +0.29% | +3.64% | +15.30% | +17.80% | 13.85B | |
| -1.21% | +2.74% | +16.77% | -30.96% | 13.18B | |
| Average | -0.30% | +0.42% | +66.13% | +96.63% | 24.49B | |
| Weighted average by Cap. | -0.31% | +0.69% | +79.60% | +118.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.84M 12.41M 10.03M 9.21M 17.42M 1.2B 17.73M 120M 46.89M 585M 46.58M 45.56M 2.01B | 44.83M 51.31M 41.48M 38.07M 72.02M 4.94B 73.31M 495M 194M 2.42B 193M 188M 8.33B |
| Net income | -31.17M -35.68M -28.84M -26.47M -50.08M -3.44B -50.98M -344M -135M -1.68B -134M -131M -5.79B | 5.02M 5.75M 4.65M 4.27M 8.07M 554M 8.21M 55.41M 21.72M 271M 21.58M 21.11M 933M |
| Net Debt | 38.68M 44.28M 35.79M 32.85M 62.14M 4.26B 63.26M 427M 167M 2.09B 166M 163M 7.19B | 14.72M 16.84M 13.62M 12.5M 23.64M 1.62B 24.07M 162M 63.64M 794M 63.22M 61.84M 2.73B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-16 | CHF 11.42 | -0.35% | 59,910 |
| 26-07-15 | CHF 11.46 | -1.04% | 78,260 |
| 26-07-14 | CHF 11.58 | -1.36% | 26,226 |
| 26-07-13 | CHF 11.74 | -0.51% | 34,169 |
| 26-07-10 | CHF 11.80 | -1.99% | 43,258 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NWRN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
